ASS 51

Known as: ASS-51, L-Cysteinamide, N- ((1-mercaptocyclohexyl)acetyl)-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)-1-methylethyl)-, cyclic (1-5)-disulfide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2012
01219842012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
To overcome the drawback of catalytic wet air oxidation (CWAO) with high temperature and high pressure, the catalytic activity of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
Chagas disease continues to be one of the main parasitic diseases in Latin America. Despite the fact that it was discovered more… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
Ziel der vorliegenden Studie war es zu prüfen, ob zwischen dem Ernährungszustand von Hartkiefern und ihrer Wuchsleistung… (More)
Is this relevant?
1999
1999
The in vivo effects of three new analogs of somatostatin (ASS-51, ASS-52 and ASS-53 analogs) on GH, insulin and glucagon were… (More)
Is this relevant?
1997
1997
The effects of somatostatin analogues octreotide (SMS 201-995), ASS-51 and ASS-52 on [3H]-thymidine incorporation into DNA of the… (More)
Is this relevant?
1993
1993
The antiproliferative activity of two new somatostatin (SS) analogs: ASS-51 and ASS-52 have been tested in this study. We… (More)
Is this relevant?
1984
1984
A number of 1,4-di-(3,4-disubstituted benzoyl)piperazines (3-6), 1-(3,4-disubstituted benzoyl)-4-(3,4-disubstituted phenyl… (More)
Is this relevant?